{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"Potential genomic changes following low dose daily oral clofarabine administration will be assessed.","groups":[{"description":"All participants enrolled.","id":"OG000","title":"All Patients"}],"populationDescription":"Data were not collected and the outcome measure was not analyzed","reportingStatus":"POSTED","timeFrame":"through end of treatment","title":"The Effect of Low Dose Daily Oral Clofarabine on Global Methylation in Patients With MDS.","type":"SECONDARY"}